Berko Milleit
Jena, TH 07743, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Brain Derived Neurotrophic Factor Deficiency is Associated with Cognitive Impairment and Elevated Phospholipase A2 Activity in Plasma of Mice.
Journal: Neuroscience
Published: November 02, 2020
Disturbed glutathione antioxidative defense is associated with structural brain changes in neuroleptic-naïve first-episode psychosis patients.
Journal: Prostaglandins, leukotrienes, and essential fatty acids
Published: November 09, 2016
Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
Journal: Schizophrenia research
Published: September 03, 2016
Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia.
Journal: Frontiers in cellular neuroscience
Published: November 01, 2015
Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.
Journal: PloS one
Published: July 01, 2015
Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis.
Journal: Prostaglandins, leukotrienes, and essential fatty acids
Published: March 21, 2015
Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
Journal: Schizophrenia research
Published: March 08, 2015
Skin ceramide alterations in first-episode schizophrenia indicate abnormal sphingolipid metabolism.
Journal: Schizophrenia bulletin
Published: May 17, 2012
Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.
Journal: Molecular psychiatry
Published: November 28, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026